{"coredata": {"prism:url": "https://api.elsevier.com/content/article/pii/S1093326311001410", "dc:identifier": "doi:10.1016/j.jmgm.2011.10.001", "eid": "1-s2.0-S1093326311001410", "prism:doi": "10.1016/j.jmgm.2011.10.001", "pii": "S1093-3263(11)00141-0", "dc:title": "Predictive QSAR modeling of phosphodiesterase 4 inhibitors ", "prism:publicationName": "Journal of Molecular Graphics and Modelling", "prism:aggregationType": "Journal", "prism:issn": "10933263", "prism:volume": "32", "prism:startingPage": "32", "prism:endingPage": "38", "prism:pageRange": "32-38", "dc:format": "application/json", "prism:coverDate": "2012-02-29", "prism:coverDisplayDate": "February 2012", "prism:copyright": "Copyright \u00a9 2011 Elsevier Inc. All rights reserved.", "prism:publisher": "Elsevier Inc.", "dc:creator": [{"@_fa": "true", "$": "Kovalishyn, Vasyl"}, {"@_fa": "true", "$": "Tanchuk, Vsevolod"}, {"@_fa": "true", "$": "Charochkina, Larisa"}, {"@_fa": "true", "$": "Semenuta, Ivan"}, {"@_fa": "true", "$": "Prokopenko, Volodymyr"}], "dc:description": "\n               Abstract\n               \n                  A series of diverse organic compounds, phosphodiesterase type 4 (PDE-4) inhibitors, have been modeled using a QSAR-based approach. 48 QSAR models were compared by following the same procedure with different combinations of descriptors and machine learning methods. QSAR methodologies used random forests and associative neural networks. The predictive ability of the models was tested through leave-one-out cross-validation, giving a Q\n                     2\n                     =0.66\u20130.78 for regression models and total accuracies Ac=0.85\u20130.91 for classification models. Predictions for the external evaluation sets obtained accuracies in the range of 0.82\u20130.88 (for active/inactive classifications) and Q\n                     2\n                     =0.62\u20130.76 for regressions. The method showed itself to be a potential tool for estimation of IC50 of new drug-like candidates at early stages of drug development.\n               \n            ", "openaccess": "0", "openaccessArticle": false, "openaccessType": null, "openArchiveArticle": false, "openaccessSponsorName": null, "openaccessSponsorType": null, "openaccessUserLicense": null, "dcterms:subject": [{"@_fa": "true", "$": "PDE-4 inhibitors"}, {"@_fa": "true", "$": "Drug design"}, {"@_fa": "true", "$": "QSAR"}, {"@_fa": "true", "$": "Artificial neural networks"}, {"@_fa": "true", "$": "Random forest"}], "link": [{"@href": "https://api.elsevier.com/content/article/pii/S1093326311001410", "@rel": "self", "@_fa": "true"}, {"@href": "https://www.sciencedirect.com/science/article/pii/S1093326311001410", "@rel": "scidir", "@_fa": "true"}]}, "scopus-id": "82255192365", "scopus-eid": "2-s2.0-82255192365", "pubmed-id": "22023934", "link": {"@href": "https://api.elsevier.com/content/abstract/scopus_id/82255192365", "@rel": "abstract"}, "originalText": {"xocs:doc": {"xocs:meta": {"xocs:open-access": {"xocs:oa-article-status": {"@is-open-access": "0", "@is-open-archive": "0"}}, "xocs:available-online-date": {"@yyyymmdd": "20111014", "$": "2011-10-14"}}}}}